share_log

Beijing Wandong Medical Technology Co.,Ltd. (SHSE:600055) Pays A CN¥0.13 Dividend In Just Three Days

Beijing Wandong Medical Technology Co.,Ltd. (SHSE:600055) Pays A CN¥0.13 Dividend In Just Three Days

北京萬東醫療技術有限公司, Ltd.(上海證券交易所股票代碼:600055)在短短三天內支付了0.13元人民幣的股息
Simply Wall St ·  05/13 08:22

Beijing Wandong Medical Technology Co.,Ltd. (SHSE:600055) stock is about to trade ex-dividend in three days. The ex-dividend date occurs one day before the record date which is the day on which shareholders need to be on the company's books in order to receive a dividend. It is important to be aware of the ex-dividend date because any trade on the stock needs to have been settled on or before the record date. In other words, investors can purchase Beijing Wandong Medical TechnologyLtd's shares before the 17th of May in order to be eligible for the dividend, which will be paid on the 17th of May.

北京萬東醫療技術有限公司, Ltd.(上海證券交易所股票代碼:600055)股票即將在三天後進行除息交易。除息日發生在記錄日期的前一天,即股東需要在公司賬簿上登記才能獲得股息的日子。注意除息日很重要,因爲任何股票交易都必須在記錄日當天或之前結算。換句話說,投資者可以在5月17日之前購買北京萬東醫療科技有限公司的股票,以便有資格獲得股息,股息將於5月17日支付。

The company's next dividend payment will be CN¥0.13 per share, and in the last 12 months, the company paid a total of CN¥0.13 per share. Looking at the last 12 months of distributions, Beijing Wandong Medical TechnologyLtd has a trailing yield of approximately 0.9% on its current stock price of CN¥15.20. If you buy this business for its dividend, you should have an idea of whether Beijing Wandong Medical TechnologyLtd's dividend is reliable and sustainable. So we need to check whether the dividend payments are covered, and if earnings are growing.

該公司的下一次股息將爲每股0.13元人民幣,在過去的12個月中,該公司共支付了每股0.13元人民幣。從過去12個月的分配情況來看,北京萬東醫療科技有限公司的追蹤收益率約爲0.9%,而目前的股價爲15.20元人民幣。如果你收購這家企業是爲了分紅,你應該知道北京萬東醫療科技有限公司的股息是否可靠和可持續。因此,我們需要檢查股息支付是否包括在內,以及收益是否在增長。

If a company pays out more in dividends than it earned, then the dividend might become unsustainable - hardly an ideal situation. Fortunately Beijing Wandong Medical TechnologyLtd's payout ratio is modest, at just 48% of profit. Yet cash flow is typically more important than profit for assessing dividend sustainability, so we should always check if the company generated enough cash to afford its dividend. Dividends consumed 57% of the company's free cash flow last year, which is within a normal range for most dividend-paying organisations.

如果一家公司支付的股息超過其收入,那麼股息可能會變得不可持續,這並不是一個理想的情況。幸運的是,北京萬東醫療科技有限公司的派息率不高,僅佔利潤的48%。然而,在評估股息可持續性方面,現金流通常比利潤更重要,因此我們應始終檢查公司產生的現金是否足以支付股息。去年,分紅消耗了公司自由現金流的57%,這對於大多數支付股息的組織來說在正常範圍內。

It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.

令人鼓舞的是,股息由利潤和現金流共同支付。這通常表明,只要收益不急劇下降,股息是可持續的。

Click here to see how much of its profit Beijing Wandong Medical TechnologyLtd paid out over the last 12 months.

點擊此處查看北京萬東醫療科技有限公司在過去12個月中支付了多少利潤。

historic-dividend
SHSE:600055 Historic Dividend May 13th 2024
SHSE: 600055 歷史股息 2024 年 5 月 13 日

Have Earnings And Dividends Been Growing?

收益和股息一直在增長嗎?

Stocks with flat earnings can still be attractive dividend payers, but it is important to be more conservative with your approach and demand a greater margin for safety when it comes to dividend sustainability. If earnings decline and the company is forced to cut its dividend, investors could watch the value of their investment go up in smoke. With that in mind, we're not enthused to see that Beijing Wandong Medical TechnologyLtd's earnings per share have remained effectively flat over the past five years. We'd take that over an earnings decline any day, but in the long run, the best dividend stocks all grow their earnings per share.

收益持平的股票仍然可以成爲有吸引力的股息支付者,但重要的是要更加保守,在股息可持續性方面要求更大的安全餘地。如果收益下降而公司被迫削減股息,投資者可能會看到他們的投資價值化爲烏有。考慮到這一點,我們並不熱衷於看到北京萬東醫療科技有限公司的每股收益在過去五年中實際上保持不變。我們隨時都會以此取代收益的下降,但從長遠來看,最好的股息股票的每股收益都會增長。

Many investors will assess a company's dividend performance by evaluating how much the dividend payments have changed over time. Since the start of our data, 10 years ago, Beijing Wandong Medical TechnologyLtd has lifted its dividend by approximately 19% a year on average.

許多投資者將通過評估股息支付在一段時間內發生了多大變化來評估公司的股息表現。自10年前我們的數據開始以來,北京萬東醫療科技有限公司已將其股息平均每年提高約19%。

The Bottom Line

底線

Has Beijing Wandong Medical TechnologyLtd got what it takes to maintain its dividend payments? Its earnings per share are effectively flat in recent times. The company paid out less than half its income and more than half its cash flow as dividends to shareholders. In summary, it's hard to get excited about Beijing Wandong Medical TechnologyLtd from a dividend perspective.

北京萬東醫療科技有限公司有能力維持其股息支付嗎?最近,其每股收益實際上持平。該公司向股東支付了不到一半的收入和一半以上的現金流作爲股息。總之,從股息的角度來看,很難對北京萬東醫療科技有限公司感到興奮。

If you're not too concerned about Beijing Wandong Medical TechnologyLtd's ability to pay dividends, you should still be mindful of some of the other risks that this business faces. In terms of investment risks, we've identified 2 warning signs with Beijing Wandong Medical TechnologyLtd and understanding them should be part of your investment process.

如果你不太擔心北京萬東醫療科技有限公司的分紅能力,你仍然應該注意該業務面臨的其他一些風險。在投資風險方面,我們已經向北京萬東醫療科技有限公司確定了兩個警告信號,並了解它們應該成爲您投資過程的一部分。

Generally, we wouldn't recommend just buying the first dividend stock you see. Here's a curated list of interesting stocks that are strong dividend payers.

通常,我們不建議只購買你看到的第一隻股息股票。以下是精選的具有強大股息支付能力的有趣股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論